ARCHIVES

The Philadelphia Story: How Surprise Filing by Abramson Spurred Penn to Follow Suit

This article is from The Cancer Letter archive.

Vol. 38 No. 11 | March 16, 2012

Download PDF Visit The Full Archive

Related Articles

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

April 25, 2014

Preventive Services Task Force Urges Colorectal Cancer Screening for 50 and Up; Advises Against Tamoxifen for Women at Low to Average Breast Cancer Risk

July 19, 2002

Minimally Invasive Surgery Results In Lower Mortality Rate For Esophageal Removal

April 25, 2003

Rich Left AMC “For Personal Reasons”

April 21, 1989

Wynder Group Finds No Association Between Coffee, Pancreatic Cancer

August 19, 1983

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

December 30, 2011